These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 23957433)

  • 1. Effectiveness and tolerability of tapentadol prolonged release compared with prior opioid therapy for the management of severe, chronic osteoarthritis pain.
    Steigerwald I; Schenk M; Lahne U; Gebuhr P; Falke D; Hoggart B
    Clin Drug Investig; 2013 Sep; 33(9):607-19. PubMed ID: 23912473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tapentadol in cancer pain pharmacotherapy in patients with metastatic malignant disease.
    Krtinic D; Nedin Rankovic G; Petkovic I; Cvetanovic A; Conic I; Todorovic Mitic M; Radic M; Milijasevic B; Lucic Prokin A; Djordjevic V; Jovanovic H; Trajkovic H; Andjelkovic Apostolovic M; Milijasevic D; Zdravkovic R; Binic I
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):12112-12120. PubMed ID: 38164873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality use of publicly subsidised tapentadol in Australia: a population-based analysis.
    Camacho X; Schaffer AL; Brett J; Pratt N; Buckley NA; Henry D; Pearson SA
    Intern Med J; 2024 Jun; 54(6):941-950. PubMed ID: 38299430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin popping with tapentadol: New challenges in the ongoing opioid crisis.
    Yogitha P; Gopinath H
    Indian J Pharmacol; 2023; 55(6):412-413. PubMed ID: 38174541
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of severe chronic pain with tapentadol prolonged release - long-term data from pain specialists.
    Strick V
    Curr Med Res Opin; 2014 Oct; 30(10):2085-92. PubMed ID: 24983745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly-A Subgroup Analysis of Routine Clinical Practice Data.
    Schwittay A; Sohns M; Heckes B; Elling C
    Pain Res Manag; 2020; 2020():5759265. PubMed ID: 32351639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tapentadol: an effective option for the treatment of back pain.
    Coluzzi F; Polati E; Freo U; Grilli M
    J Pain Res; 2019; 12():1521-1528. PubMed ID: 31190963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tapentadol Prolonged Release: A Review in Pain Management.
    Deeks ED
    Drugs; 2018 Nov; 78(17):1805-1816. PubMed ID: 30471002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain.
    Pergolizzi JV; Taylor R; LeQuang JA; Raffa RB; Bisney J
    Pain Ther; 2018 Jun; 7(1):37-57. PubMed ID: 29623654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Rotation in Cancer Pain Treatment.
    Schuster M; Bayer O; Heid F; Laufenberg-Feldmann R
    Dtsch Arztebl Int; 2018 Mar; 115(9):135-142. PubMed ID: 29563006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The switch from buprenorphine to tapentadol: is it worth?
    Miclescu A
    Rom J Anaesth Intensive Care; 2016 Oct; 23(2):133-139. PubMed ID: 28913486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide research productivity on tramadol: a bibliometric analysis.
    Sweileh WM; Shraim NY; Zyoud SH; Al-Jabi SW
    Springerplus; 2016; 5(1):1108. PubMed ID: 27478725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tapentadol prolonged release for severe chronic cancer-related pain: effectiveness, tolerability, and influence on quality of life of the patients.
    Schikowski A; Krings D; Schwenke K
    J Pain Res; 2015; 8():1-8. PubMed ID: 25565884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tapentadol prolonged release for severe chronic pain: results of a noninterventional study involving general practitioners and internists.
    Schwittay A; Schumann C; Litzenburger BC; Schwenke K
    J Pain Palliat Care Pharmacother; 2013 Aug; 27(3):225-34. PubMed ID: 23957433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tapentadol prolonged release for severe chronic pain. Results of a non-interventional study involving general practitioners and internists].
    Schwittay A; Schumann C; Litzenburger BC; Schwenke K
    MMW Fortschr Med; 2012 Oct; 154 Suppl 3():85-93. PubMed ID: 23133884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tapentadol prolonged release for the treatment of severe chronic tumor pain in routine clinical practice].
    Agbalaka A; Schwenke K; Litzenburger B
    MMW Fortschr Med; 2012 Dec; 154 Suppl 4():123-30. PubMed ID: 23326931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone].
    Kern KU; Krings D; Waldmann-Rex S
    MMW Fortschr Med; 2014 Jul; 156 Suppl 2():54-63. PubMed ID: 25351028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical considerations for the use of tapentadol prolonged release for the management of severe chronic pain.
    Sánchez Del Águila MJ; Schenk M; Kern KU; Drost T; Steigerwald I
    Clin Ther; 2015 Jan; 37(1):94-113. PubMed ID: 25108647
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.